Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1
- PMID: 9743498
- DOI: 10.1126/science.281.5384.1851
Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1
Abstract
Analysis of transgenic mice expressing familial amyotrophic lateral sclerosis (ALS)-linked mutations in the enzyme superoxide dismutase (SOD1) have shown that motor neuron death arises from a mutant-mediated toxic property or properties. In testing the disease mechanism, both elimination and elevation of wild-type SOD1 were found to have no effect on mutant-mediated disease, which demonstrates that the use of SOD mimetics is unlikely to be an effective therapy and raises the question of whether toxicity arises from superoxide-mediated oxidative stress. Aggregates containing SOD1 were common to disease caused by different mutants, implying that coaggregation of an unidentified essential component or components or aberrant catalysis by misfolded mutants underlies a portion of mutant-mediated toxicity.
Similar articles
-
Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex.J Biol Chem. 2007 Jun 1;282(22):16691-9. doi: 10.1074/jbc.M609743200. Epub 2007 Apr 2. J Biol Chem. 2007. PMID: 17403682
-
Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis.J Biol Chem. 2013 May 31;288(22):15699-711. doi: 10.1074/jbc.M112.425066. Epub 2013 Apr 16. J Biol Chem. 2013. PMID: 23592792 Free PMC article.
-
Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis.J Neurosci. 2005 Jan 5;25(1):108-17. doi: 10.1523/JNEUROSCI.4253-04.2005. J Neurosci. 2005. PMID: 15634772 Free PMC article.
-
Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation.Neuropathology. 2001 Mar;21(1):82-92. doi: 10.1046/j.1440-1789.2001.00361.x. Neuropathology. 2001. PMID: 11304046 Review.
-
New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations: inclusions containing SOD1 in neurons and astrocytes.Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Jun;1(3):163-84. doi: 10.1080/14660820050515160. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000. PMID: 11464950 Review.
Cited by
-
Rhodopsin gene expression determines rod outer segment size and rod cell resistance to a dominant-negative neurodegeneration mutant.PLoS One. 2012;7(11):e49889. doi: 10.1371/journal.pone.0049889. Epub 2012 Nov 21. PLoS One. 2012. PMID: 23185477 Free PMC article.
-
Role and therapeutic potential of liquid-liquid phase separation in amyotrophic lateral sclerosis.J Mol Cell Biol. 2021 Apr 10;13(1):15-28. doi: 10.1093/jmcb/mjaa049. J Mol Cell Biol. 2021. PMID: 32976566 Free PMC article. Review.
-
The complex molecular biology of amyotrophic lateral sclerosis (ALS).Prog Mol Biol Transl Sci. 2012;107:215-62. doi: 10.1016/B978-0-12-385883-2.00002-3. Prog Mol Biol Transl Sci. 2012. PMID: 22482452 Free PMC article. Review.
-
ALS mutant SOD1 interacts with G3BP1 and affects stress granule dynamics.Acta Neuropathol. 2016 Oct;132(4):563-76. doi: 10.1007/s00401-016-1601-x. Epub 2016 Aug 1. Acta Neuropathol. 2016. PMID: 27481264 Free PMC article.
-
Genetic biomarkers for ALS disease in transgenic SOD1(G93A) mice.PLoS One. 2012;7(3):e32632. doi: 10.1371/journal.pone.0032632. Epub 2012 Mar 7. PLoS One. 2012. PMID: 22412900 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous